Archeus Technologies
Phase 1We are developing targeted, patient-specific therapies for some of the hardest-to-treat cancers. We aren’t satisfied with limited lifetime extensions. Our unique cancer-targeting agents and treatment approach offer the potential for truly curative responses in historically terminal diseases.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
We are developing targeted, patient-specific therapies for some of the hardest-to-treat cancers. We aren’t satisfied with limited lifetime extensions. Our unique cancer-targeting agents and treatment approach offer the potential for truly curative responses in historically terminal diseases.
Radiopharmaceuticals